Niacin Beats Ezetimibe Head to Head

Elliott, William T.
January 2010
Internal Medicine Alert;1/15/2010 Supplement 1, p1
The article discusses several studies on the impact of statins and niacin on high-density lipoprotein cholesterol (HDL-C), the role of omeprazole on the efficacy of clopidogrel, and the effect of darbepoetin on the risk of stroke in the U.S.


Related Articles

  • In vitro Evaluation of Phototoxic Properties of Proton Pump Inhibitors, H2-receptor Antagonists and Statins. Gebhardt, Evi; Eberlein, Bernadette; Przybilla, Bernhard; Gilbertz, Klaus-Peter; Placzek, Marianne // Acta Dermato-Venereologica;2012, Vol. 92 Issue 2, p208 

    The article presents a study which investigates the phototoxic potential of Histamine 2 receptor antagonists, proton pump inhibitors and statins utilizing a photohaemolysis test. The findings reveal that pantoprazole, esomeprazole and omeprazole exerted phototoxic effects following an exposure...

  • Niacin Beats Ezetimibe Head to Head.  // Travel Medicine Advisor;Jan2010 Supplement, p1 

    The article offers updates on several drugs from the U.S. Food and Drug Administration (FDA). A study revealed that adding niacin to statin increases HDL-cholesterol (HDL-C). FDA has issued a notice which concerns the effects of combining clopidogrel (Plavix) with omeprazole (Prilosec). Research...

  • Statin-Associated Polymyositis Following Omeprazole Treatment. Kanth, Rajan; Shah, Milind S.; Flores, Rafael Medina // Clinical Medicine & Research;Jun2013, Vol. 11 Issue 2, p91 

    Statins are an extensively used class of drugs, and myopathy is an uncommon, but well-described side effect of statin therapy. Inflammatory myopathies, including polymyositis, dermatomyositis, and necrotizing autoimmune myopathy, are even more rare, but debilitating, side effects of statin...

  • Myopathy including polymyositis: a likely class adverse effect of proton pump inhibitors? Clark, David W. J.; Strandell, Johanna // European Journal of Clinical Pharmacology;Jun2006, Vol. 62 Issue 6, p473 

    Objective: Polymyositis occurring in patients treated with omeprazole has been signalled as a possible adverse drug reaction (ADR) by the New Zealand Intensive Medicines Monitoring Programme (IMMP) and the WHO Collaborating Centre for International Drug Monitoring: the Uppsala Monitoring Centre...

  • Super Boy Has Massive Muscles.  // Current Health 2;Nov2004, Vol. 31 Issue 3, p6 

    Deals with the effect of the protein myostatin on the skeletal muscle.

  • Implementation of a therapeutic-interchange clinic for HMG-CoA reductase inhibitors. Grace, Karen A.; Sweicki, Jennifer; Hyatt, Richard; Gibbs, Henny; Jones, David l.; Sheikh, Munazza; Spain, John; Maneval, Kent W.; Viola, Rebecca; Taylor, Allen J. // American Journal of Health-System Pharmacy;6/1/2002, Vol. 59 Issue 11, p1077 

    Focuses on the implementation of a therapeutic-interchange clinic for HMG-CoA reductase inhibitors. United States Department of Defense's use of cerivastatin and simvastatin.

  • FDA Drug Approvals: Crestor.  // Formulary;Sep2003, Vol. 38 Issue 9, p509 

    Offers information on the pharmacology of the resuvastatin drug Crestor. Approval for treatment of lipid disorders; Performance of the drug in the treatment of patients with hypercholesterolemia; Contraindication of resuvastatin in liver disease or persistent elevations of serum transaminases.

  • Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary Syndromes.  // New England Journal of Medicine;2/16/2006, Vol. 354 Issue 7, p778 

    A correction to the article "Intensive Versus Moderate Lipid Lowering with Statins After Acute Coronary Syndromes" that was published in the April 8, 2005 issue is presented.

  • The Impact of the Use of Statins on the Prevalence of Dementia and the Progression of Cognitive Impairment. Hajjar, Ihab; Schumpert, Jeannie; Hirth, Victor; Wieland, Darryl; Eleazar, G. Paul // Journals of Gerontology Series A: Biological Sciences & Medical ;Jul2002, Vol. 57 Issue 7, pM414 

    Focuses on a study which investigated the association between the use of statins and the prevalence of dementia in Columbia, South Carolina. Examination of the impact of statin on the progression of cognitive impairment; Characteristics of subjects; Results and discussion; Limitations of the study.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics